Hakim Mazouz

1.2k total citations
33 papers, 712 citations indexed

About

Hakim Mazouz is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Transplantation. According to data from OpenAlex, Hakim Mazouz has authored 33 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Transplantation. Recurrent topics in Hakim Mazouz's work include Renal Transplantation Outcomes and Treatments (9 papers), Blood Pressure and Hypertension Studies (7 papers) and Renin-Angiotensin System Studies (7 papers). Hakim Mazouz is often cited by papers focused on Renal Transplantation Outcomes and Treatments (9 papers), Blood Pressure and Hypertension Studies (7 papers) and Renin-Angiotensin System Studies (7 papers). Hakim Mazouz collaborates with scholars based in France, United States and China. Hakim Mazouz's co-authors include Albert Fournier, Jean Michel Achard, Jean‐Michel Achard, É. Thervet, Roxana Oprisiu, A. El Moumen, T. Kanit, Antoine Thierry, Olivier Toupance and A.‐E. Heng and has published in prestigious journals such as Kidney International, Biochemical Pharmacology and Composites Part B Engineering.

In The Last Decade

Hakim Mazouz

31 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hakim Mazouz France 14 222 186 141 135 109 33 712
Michelle M. Nash Canada 17 301 1.4× 98 0.5× 119 0.8× 213 1.6× 86 0.8× 50 757
Pieter C. Vos Netherlands 13 156 0.7× 50 0.3× 119 0.8× 244 1.8× 99 0.9× 25 729
Lars Kihm Germany 19 102 0.5× 146 0.8× 366 2.6× 215 1.6× 17 0.2× 56 982
Luís Henrique Wolff Gowdak Brazil 18 86 0.4× 476 2.6× 185 1.3× 457 3.4× 22 0.2× 76 1.2k
Christopher Reid United Kingdom 15 52 0.2× 95 0.5× 240 1.7× 87 0.6× 31 0.3× 35 624
Atli Eyjolfsson Sweden 9 102 0.5× 202 1.1× 26 0.2× 452 3.3× 20 0.2× 15 723
Bernhard Floerchinger Germany 15 129 0.6× 129 0.7× 35 0.2× 350 2.6× 23 0.2× 42 624
Beatriz Tucker United Kingdom 12 27 0.1× 159 0.9× 268 1.9× 77 0.6× 26 0.2× 18 746
Tomasz Hryszko Poland 16 19 0.1× 111 0.6× 214 1.5× 140 1.0× 13 0.1× 74 703
Héctor Rodríguez Cetina Biefer Switzerland 20 105 0.5× 541 2.9× 17 0.1× 629 4.7× 27 0.2× 64 1.2k

Countries citing papers authored by Hakim Mazouz

Since Specialization
Citations

This map shows the geographic impact of Hakim Mazouz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakim Mazouz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakim Mazouz more than expected).

Fields of papers citing papers by Hakim Mazouz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakim Mazouz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakim Mazouz. The network helps show where Hakim Mazouz may publish in the future.

Co-authorship network of co-authors of Hakim Mazouz

This figure shows the co-authorship network connecting the top 25 collaborators of Hakim Mazouz. A scholar is included among the top collaborators of Hakim Mazouz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakim Mazouz. Hakim Mazouz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laurent, Pierre, Claire Presne, Maïté Jaureguy, et al.. (2023). Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients. Advances in Therapy. 40(9). 3956–3970. 2 indexed citations
2.
Marquet, Pierre, Alexandre Destère, Caroline Monchaud, et al.. (2020). Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients. Clinical Pharmacokinetics. 60(5). 611–622. 13 indexed citations
3.
Moumen, A. El, et al.. (2016). Random versus periodic microstructures for elasticity of fibers reinforced composites. Composites Part B Engineering. 103. 68–73. 55 indexed citations
4.
Cassuto, Élisabeth, Georges‐Philippe Pageaux, Diego Cantarovich, et al.. (2016). Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant. Transplantation. 100(10). 2099–2106. 27 indexed citations
5.
Mazouz, Hakim, et al.. (2015). Optimization of the Conditions of Machining Based on a Criterion Combined by Genetic Algorithms. 3(4). 100–104. 1 indexed citations
6.
Meur, Yannick Le, Markus W. Büchler, Marie‐Christine Moal, et al.. (2014). Everold: A Multicenter Randomized Study for the Use of Everolimus in “Old-for-Old” Renal Transplantation.. Transplantation. 98. 114–114. 5 indexed citations
7.
Mazouz, Hakim, et al.. (2013). Impact of renal graft nephrectomy on second kidney transplant survival. International Urology and Nephrology. 45(1). 87–92. 19 indexed citations
8.
Fournier, Albert, Jean‐Marie Sérot, Olivier Godefroy, et al.. (2009). Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Expert Review of Neurotherapeutics. 9(9). 1413–1431. 104 indexed citations
9.
Choukroun, Gabriel, Gilbert Deray, Denis Glotz, et al.. (2008). Incidence et prise en charge de l’anémie en transplantation rénale : une étude observationnelle française. Néphrologie & Thérapeutique. 4(7). 575–583. 8 indexed citations
10.
Boutitie, Florent, Roxana Oprisiu, Jean Michel Achard, et al.. (2007). Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke?. Journal of Hypertension. 25(8). 1543–1553. 25 indexed citations
11.
Büchler, M., Sophie Caillard, S. Barbier, et al.. (2007). Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6‐Month Course of Steroids. American Journal of Transplantation. 7(11). 2522–2531. 148 indexed citations
12.
Monge, M., Hakim Mazouz, Claire Presne, et al.. (2007). Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation. Nephrology Dialysis Transplantation. 22(7). 1979–1985. 11 indexed citations
13.
Shahapuni, I., Matthieu Monge, Roxana Oprisiu, et al.. (2006). Drug Insight: renal indications of calcimimetics. Nature Clinical Practice Nephrology. 2(6). 316–325. 9 indexed citations
14.
Moisan, A., et al.. (2005). Evaluation of the dynamic cutting force coefficients under dynamic behaviour. Matériaux & Techniques. 93(9-12). 369–373. 1 indexed citations
15.
Achard, Jean Michel, Florent Boutitie, Hakim Mazouz, et al.. (2004). Is the angiotensin ii type 2 receptor cerebroprotective?. Current Hypertension Reports. 6(3). 182–189. 22 indexed citations
16.
17.
Mazouz, Hakim, C Hottelart, Patrice Fardellone, et al.. (2000). Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney International. 58(4). 1788–1796. 53 indexed citations
18.
Mazouz, Hakim, Ina Maria Kacsó, N. El Esper, et al.. (1999). Risk factors of renal failure progression two years prior to dialysis.. PubMed. 51(6). 355–66. 12 indexed citations
19.
Fournier, A, Roxana Darabont, Hakim Mazouz, et al.. (1999). [Duality of angiotensin II receptors and risk for stroke and cancer: what is the connection?].. PubMed. 28(17). 918–22. 4 indexed citations
20.
Fournier, A., P. Morinière, Roxana Oprisiu, et al.. (1995). 1-Alpha-Hydroxyvitamin D<sub>3 </sub>Derivatives in the Treatment of Renal Bone Diseases: Justification and Optimal Modalities of Administration. ˜The œNephron journals/Nephron journals. 71(3). 254–283. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle M. Nash Breakdown of academic impact, for papers by Pieter C. Vos Breakdown of academic impact, for papers by Lars Kihm Breakdown of academic impact, for papers by Luís Henrique Wolff Gowdak Breakdown of academic impact, for papers by Christopher Reid Breakdown of academic impact, for papers by Atli Eyjolfsson Breakdown of academic impact, for papers by Bernhard Floerchinger Breakdown of academic impact, for papers by Beatriz Tucker Breakdown of academic impact, for papers by Tomasz Hryszko Breakdown of academic impact, for papers by Héctor Rodríguez Cetina Biefer
Rankless by CCL
2026